Cargando…

Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report

Small cell carcinoma of the urinary bladder is a rare subtype (incidence of 1–9/1,000,000), characterized by an aggressive behavior with early metastasis and poor prognosis. Chemotherapy, radiation, and surgery are the usual treatment options, but to date, no accepted standard treatment exists. Sinc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Olav Toai Duc, Sundstrøm, Stein Harald, Westvik, Ganna Surzhykova, Røttereng, Ane Karoline Stræte, Melhus, Mona Røli, Bergseth, Cecilie, Hallem, Elisabeth Kvelstad, Røe, Oluf Dimitri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548951/ https://www.ncbi.nlm.nih.gov/pubmed/33082749 http://dx.doi.org/10.1159/000509747

Ejemplares similares

Headache as a predictor for dementia: The HUNT Study
por: Røttereng, Ane Karoline Stræte, et al.
Publicado: (2015)

‘Reduced’ HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial
por: Røe, Oluf Dimitri, et al.
Publicado: (2019)

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
por: Cyriac, Sanju, et al.
Publicado: (2021)

Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
por: Kadota, Naoki, et al.
Publicado: (2021)

Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma
por: Senda, Masaya, et al.
Publicado: (2023)

Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report
por: Lepir, Tanja, et al.
Publicado: (2019)

Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer
por: Chan, John K., et al.
Publicado: (2020)

Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
por: Gorshein, Elan, et al.
Publicado: (2021)

Pembrolizumab-Induced Vitiligo in Esophageal Squamous Cell Carcinoma Patient With Durable Complete Response
por: Wilkins, Matthew C, et al.
Publicado: (2021)

Democratic and ethical problem of lung cancer screening: exclusion of true high-risk populations. Can it be fixed? Yes
por: Røe, Oluf Dimitri
Publicado: (2020)

Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma
por: Røe, Oluf Dimitri, et al.
Publicado: (2012)

PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab
por: George, Saby, et al.
Publicado: (2018)

Single pembrolizumab treatment causing profound durable response in a patient with pulmonary pleomorphic carcinoma
por: Tokuyasu, Hirokazu, et al.
Publicado: (2019)

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer
por: Poma, Anello Marcello, et al.
Publicado: (2021)

A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer
por: Kondo, Yoshihiro, et al.
Publicado: (2022)

A complete durable response of vaginal clear cell carcinoma with pembrolizumab: A case report
por: Porragas-Paseiro, Hector S., et al.
Publicado: (2023)

Modified Nanofibrous Filters with Durable Antibacterial Properties
por: Ungur, Ganna, et al.
Publicado: (2021)

Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review
por: Panou, Vasiliki, et al.
Publicado: (2020)

Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
por: Khetan, Varun, et al.
Publicado: (2021)

Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
por: Røe, Oluf Dimitri, et al.
Publicado: (2015)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
por: Zeng, Tian, et al.
Publicado: (2021)

The undifferentiated carcinoma that became a melanoma: Re-biopsy of a cancer of an unknown primary site: a case report
por: Røe, Oluf Dimitri, et al.
Publicado: (2017)

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab
por: Chahoud, Jad, et al.
Publicado: (2020)

Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review
por: Tan, Sirui, et al.
Publicado: (2022)

PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report
por: Sachdeva, Manavi, et al.
Publicado: (2021)

Pembrolizumab
por: Khoja, Leila, et al.
Publicado: (2015)

Methods for preprocessing time and distance series data from personal monitoring devices
por: Wiktorski, Tomasz, et al.
Publicado: (2020)

Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case report
por: Umihira, Shuntaro, et al.
Publicado: (2022)

Asbestos exposure and haematological malignancies: a Danish cohort study
por: Würtz, Else Toft, et al.
Publicado: (2020)

Pembrolizumab for all
por: Kim, Myung S., et al.
Publicado: (2022)

Robust and durable response to first-line treatment of pembrolizumab combined with chemotherapy in two patients with metastatic thymic squamous cell carcinoma: Case report
por: Chen, Cui, et al.
Publicado: (2022)

Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma
por: Kao, Chien-Hsiang, et al.
Publicado: (2022)

PSEN as an Educational Tool in Norway
por: Westvik, Tormod Schumacher
Publicado: (2017)

Hidden Treasures in “Ancient” Microarrays: Gene-Expression Portrays Biology and Potential Resistance Pathways of Major Lung Cancer Subtypes and Normal Tissue
por: Kerkentzes, Konstantinos, et al.
Publicado: (2014)

Coffee intake and development of pain during computer work
por: Strøm, Vegard, et al.
Publicado: (2012)

Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis
por: Moradi, Luke A., et al.
Publicado: (2021)

T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma
por: Moskowitz, Alison J., et al.
Publicado: (2022)

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy
por: Murakami, Shuji, et al.
Publicado: (2020)

Artifact Correction in Short-Term HRV during Strenuous Physical Exercise
por: Królak, Aleksandra, et al.
Publicado: (2020)

Into the Clinic With Nivolumab and Pembrolizumab
por: Shu, Catherine A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_reqhn84ggfqu36urrjvt5stl6b